2018
Histiocytic Glomerulopathy as a Manifestation of Macrophage Activation Syndrome
Kaur A, Diaz-Perez J, Weiner R, Cibull T, Sarav M, Victor T. Histiocytic Glomerulopathy as a Manifestation of Macrophage Activation Syndrome. American Journal Of Clinical Pathology 2018, 150: s12-s12. DOI: 10.1093/ajcp/aqy090.029.Peer-Reviewed Original ResearchMacrophage activation syndromeAcute kidney injuryHemophagocytic lymphohistiocytosisMacrophage hyperactivationActivation syndromeEndocapillary hypercellularityManifestation of macrophage activation syndromeCases of macrophage activation syndromeFeatures of macrophage activation syndromeWorsening acute kidney injurySignificant postpartum hemorrhageLow complement levelsCytotoxic T lymphocytesElevated lipase levelsExcessive macrophage activationNatural killer cellsAcute tubular necrosisConnective tissue disordersPrimary genetic alterationIntensive care unitPostpartum coursePostpartum hemorrhageSevere preeclampsiaUncomplicated pregnanciesAnti-SSA
2017
Summary Points and Consensus Recommendations From the International Protein Summit
Hurt R, McClave S, Martindale R, Gautier J, Coss‐Bu J, Dickerson R, Heyland D, Hoffer L, Moore F, Morris C, Paddon‐Jones D, Patel J, Phillips S, Rugeles S, Sarav M, Weijs P, Wernerman J, Hamilton‐Reeves J, McClain C, Taylor B. Summary Points and Consensus Recommendations From the International Protein Summit. Nutrition In Clinical Practice 2017, 32: 142s-151s. PMID: 28388374, DOI: 10.1177/0884533617693610.Peer-Reviewed Original ResearchConceptsIntensive care unitPhase of critical illnessHigh nutritional riskInitial phase of critical illnessCritically ill patientsHealthcare professionalsMammalian target of rapamycinNutritional riskImproved insulin sensitivityDose of proteinClinical nutritionProtein goalsMuscle massNutrition therapyHigh doses of proteinClinical outcomesProtein administrationTarget of rapamycinBody protein homeostasisSummary PointsMeeting energy goalsHigh dosesNew protein synthesisProtein doseConsensus recommendations